PXR and the regulation of apoA1 and HDL-cholesterol in rodents

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Kenneth BachmannLidia Sambucetti

Abstract

Orphan nuclear receptors (ONRs) have been implicated in the regulation of lipids. Several clinical studies conducted either prospectively or epidemiologically have pointed to a link between the regulation of hepatic CYP enzymes and HDL-cholesterol (HDL-C) and/or apolipoprotein A1 (apoA1). The treatment of rats with a series of imidazole inducers of CYP3A yielded correlations between in vitro CYP3A activity measured as erythromycin demethylase activity and plasma HDL-C and hepatic apoA1 mRNA. Similarly, a correlation was established between in vivo CYP3A activity, measured as ethosuximide clearance, and plasma HDL-C and hepatic apoA1 mRNA. The treatment of wild-type (WT) mice with PXR agonists elicited increases in serum HDL-C and serum apoA1 levels. On the other hand, the treatment of PXR-knockout mice (PXR-KOs) with the same PXR agonists failed to elicit increases in either serum HDL-C or serum apoA1 levels. Superposition of the structures of three imidazoles known to be active CYP3A inducers in rats with the human PXR pharmacophore demonstrated a partial fit and predicted EC(50) values typical of weak-moderate hPXR inducers in humans. These imidazoles have been shown to increase apoA1 and HDL-C in rats and mice. Taken togethe...Continue Reading

References

Sep 1, 1991·Annals of the Rheumatic Diseases·T YamamotoK Higashino
Nov 1, 1982·Journal of Cardiovascular Pharmacology·P V LuomaE Hokkanen
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·C B Pickett, A Y Lu
Apr 1, 1980·Scandinavian Journal of Clinical and Laboratory Investigation·P V LuomaV V Myllylä
Sep 5, 1997·The Journal of Biological Chemistry·N Vu-DacB Staels
Aug 26, 1998·Biochemical Pharmacology·J T SlamaK A Bachmann
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·W XieR M Evans
Jul 19, 2001·The Journal of Biological Chemistry·T T LuD J Mangelsdorf
Dec 18, 2001·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sean Ekins, Jon A Erickson
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hans H Bock, Frank Lammert
Mar 8, 2002·Atherosclerosis·Jerzy-Roch NoferArnold von Eckardstein
May 2, 2002·Drug Discovery Today·Wen Xie, Ronald M Evans
Feb 15, 2003·FEBS Letters·Petri T Kovanen, Markku O Pentikäinen
Aug 12, 2003·Journal of Molecular Biology·Ryan E WatkinsMatthew R Redinbo
Aug 16, 2003·The Journal of Biological Chemistry·Michelle M TabbBruce Blumberg
Oct 8, 2003·Current Drug Metabolism·Dayna C Mankowski, Sean Ekins
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Steven E NissenRichard Kerensky
Apr 11, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Chenshu XuJeff L Staudinger

❮ Previous
Next ❯

Citations

Dec 31, 2008·Pharmaceutical Research·Sandhya KortagereSean Ekins
Jun 13, 2008·Chemical Research in Toxicology·Akash KhandelwalSean Ekins
Apr 4, 2008·BMC Evolutionary Biology·Sean EkinsMatthew D Krasowski
Jun 19, 2010·Environmental Health Perspectives·Sandhya KortagereSean Ekins
Dec 17, 2009·PLoS Computational Biology·Sean EkinsMatthew D Krasowski
Apr 19, 2011·Annual Review of Biochemistry·Joshua Wollam, Adam Antebi
Dec 24, 2013·Journal of Pharmacological and Toxicological Methods·Sean Ekins
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Sean EkinsTatiana Nikolskaya
Aug 1, 2006·Drug Metabolism Reviews·Lesley A StanleyC Roland Wolf
Jan 19, 2013·Expert Opinion on Drug Metabolism & Toxicology·Xiaojuan ChaiWen Xie
Nov 26, 2009·Progress in Lipid Research·Stefano FiorucciAndrea Mencarelli
Sep 8, 2010·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Geert A A NibourgRuurdtje Hoekstra
Dec 2, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Ya-He LiuShu-Feng Zhou
Feb 8, 2011·Biochimica Et Biophysica Acta·Chibueze A IhunnahWen Xie
Dec 8, 2004·Archives of Biochemistry and Biophysics·Christoph Handschin, Urs A Meyer
Nov 8, 2006·Journal of Lipid Research·Tiangang LiJohn Y L Chiang
Aug 14, 2015·International Journal of Toxicology·Tiong Chai SeahMei Lan Tan
Aug 27, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·David MassonMahfoud Assem
Feb 26, 2009·Nuclear Receptor Signaling·Changcheng ZhouBruce Blumberg
Apr 25, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kun WangYu-Jui Yvonne Wan
Feb 2, 2019·Current Topics in Medicinal Chemistry·Eleni A RekkaMaria Pantelidou
Jun 14, 2018·Infectious Diseases of Poverty·Jia ChenHany M Elsheikha
Dec 20, 2013·The Journal of Biological Chemistry·Natalia MastIrina A Pikuleva
May 29, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kazuto YasudaKenneth Bachmann
Nov 22, 2013·The Journal of Pharmacology and Experimental Therapeutics·Benjamin A KandelUlrich M Zanger
Dec 2, 2017·Bioscience Reports·Line ZurkindenGeneviève Escher

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.